No announcement yet.

Ischemic Spastic Paraplegia trial anticipated

  • Filter
  • Time
  • Show
Clear All
new posts

  • Ischemic Spastic Paraplegia trial anticipated

    Neuralstem raises $5.135 million to help fund first human trial
    Washington Business Journal - 12:16 PM EDT Tuesday, March 20, 2007by
    Neil AdlerStaff Reporter
    Print this Article Email this Article Reprints RSS Feeds Most Viewed Most Emailed
    Neuralstem hopes to begin its first human clinical trial on a stem cell product sometime this year and has raised more than $5 million to help fund the trial.

    The Rockville-based biotechnology company, whose focus is treatments
    based on the transplantation of human neural stem cells, raised about $5.14 million in a private placement of more than 2 million units at $2.50 per unit to a group of institutional investors.

    Each unit consists of one share of common stock and one half-warrant
    exercisable at $3 per share. Bedminster, N.J.-based T.R. Winston and Co. acted as the placement agent for the offering. .............

    Link :